Skip to main content

Twynsta FDA Approval History

FDA Approved: Yes (First approved October 16, 2009)
Brand name: Twynsta
Generic name: telmisartan and amlodipine
Dosage form: Tablets
Company: Boehringer Ingelheim Pharmaceuticals Inc.
Treatment for: High Blood Pressure

Twynsta (telmisartan/amlodipine) is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents.

Development timeline for Twynsta

Oct 19, 2009Approval FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.